Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Matthew J. Lim"'
Autor:
Anastasios Raptis, Alison R. Sehgal, David Weber, Matthew J. Lim, Mounzer Agha, Rafic Farah, Kathleen A. Dorritie, Annie Im, Aya Agha, Jing-Zhou Hou, Stanley M. Marks, Seah H. Lim
Publikováno v:
American Journal of Hematology. 91:291-294
Clostridium difficile infections (CDI) remain the leading cause of infectious diarrhea among hospitalized patients in this country. Patients with hematologic malignancies, especially those who undergo hematopoietic progenitor cell transplants are par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c76f5a262d3a6d699b6c23132d25ec7
https://doi.org/10.1002/ajh.24263
https://doi.org/10.1002/ajh.24263
Autor:
Jing-Zhou Hou, Kathleen A. Dorritie, Stanley M. Marks, Raymond E. Felgar, Annie Im, Matthew J. Lim, Alison R. Sehgal, Mounzer Agha, Rafic Farah, Anastasios Raptis, Seah H. Lim, Sara J. Lim
Publikováno v:
American Journal of Hematology. 90:715-718
While some patients with high-risk acute myeloid leukemia (AML) require one or two cycles of induction chemotherapy to achieve a complete remission (CR), others require more than two cycles. We examined the outcomes of patients with high-risk AML who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df3e62890f65cb3a7f63e9c985aef4df
https://doi.org/10.1002/ajh.24062
https://doi.org/10.1002/ajh.24062
Autor:
Stanley M. Marks, Annie Im, Kathleen A. Dorritie, Seah H. Lim, Sara J. Lim, Mounzer Agha, Jing-Zhou Hou, Alison R. Sehgal, Rafic Farah, Matthew J. Lim, Anastasios Raptis
Publikováno v:
European Journal of Haematology. 96:55-59
Pulmonary nodules (PNs) develop frequently in patients with acute myeloid leukemia (AML). They are of infectious or inflammatory origin. They pose potential challenges to successful hematopoietic progenitor cell (HPC) transplant as they may be niches
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b122920d33856b900a5614a75c132e0b
https://doi.org/10.1111/ejh.12547
https://doi.org/10.1111/ejh.12547
Autor:
Mounzer Agha, Matthew J. Lim, Aya Agha, Seah H. Lim, Annie Im, Michael Boyiadzis, Stanley S. Marks, Alison R. Sehgal, Robert L. Redner, Kathleen A. Dorritie, Anastasios Raptis, Jing Z. Hou
Publikováno v:
Hematological oncology. 36(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44408e26f96327983db3442120ef68bb
https://pubmed.ncbi.nlm.nih.gov/28664979
https://pubmed.ncbi.nlm.nih.gov/28664979
Autor:
Aya, Agha, Alison, Sehgal, Matthew J, Lim, David, Weber, Jing-Zhou, Hou, Rafic, Farah, Anastasios, Raptis, Annie, Im, Kathleen, Dorritie, Stanley, Marks, Mounzer, Agha, Seah H, Lim
Publikováno v:
American journal of hematology. 91(3)
Clostridium difficile infections (CDI) remain the leading cause of infectious diarrhea among hospitalized patients in this country. Patients with hematologic malignancies, especially those who undergo hematopoietic progenitor cell transplants are par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::579fe9e2d5c3e0cae761ad9e49165de9
https://pubmed.ncbi.nlm.nih.gov/26661725
https://pubmed.ncbi.nlm.nih.gov/26661725
Autor:
Annie Im, Jing-Zhou Hou, Mounzer Agha, Matthew J. Lim, Rafic Farah, Stebbings A, Foor K, Alison R. Sehgal, Anastasios Raptis, David Weber, Kathleen A. Dorritie, Stanley M. Marks, Seah H. Lim, Sara J. Lim
Publikováno v:
Bone marrow transplantation. 50(9)
IV pentamidine for primary PJP prophylaxis in adults undergoing allogeneic hematopoietic progenitor cell transplant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31fbc91962483fbf653f38a74dbd658d
https://pubmed.ncbi.nlm.nih.gov/26052915
https://pubmed.ncbi.nlm.nih.gov/26052915
Autor:
Sara J, Lim, Matthew J, Lim, Anastasios, Raptis, Jing-Zhou, Hou, Rafic, Farah, Stanley M, Marks, Annie, Im, Kathleen, Dorritie, Alison, Sehgal, Mounzer, Agha, Raymond, Felgar, Seah H, Lim
Publikováno v:
American journal of hematology. 90(8)
While some patients with high-risk acute myeloid leukemia (AML) require one or two cycles of induction chemotherapy to achieve a complete remission (CR), others require more than two cycles. We examined the outcomes of patients with high-risk AML who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0caee097053aa30a0777f1e1b6fddc6a
https://pubmed.ncbi.nlm.nih.gov/26010177
https://pubmed.ncbi.nlm.nih.gov/26010177